Phase 2 study of amrubicin in previously treated patients with malignant pleural mesothelioma.
Latest Information Update: 01 Jun 2020
At a glance
- Drugs Amrubicin (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology
- 28 May 2020 Status changed from recruiting to completed.
- 28 Sep 2011 Status of the trial is recruiting as reported by University Hospital Medical Information Network - Japan record..